Acuta Capital Partners, LLC Novavax Inc Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $311,506 - $504,600	-2,315 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $99,341 - $211,547	-821 Reduced 26.18%	2,315 $491,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $71,855 - $203,475	636 Added 25.44%	3,136 $569,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $196,850 - $348,750	2,500 New	2,500 $279,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.